Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBIDECARENONE vs UPADACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBIDECARENONE vs UPADACITINIB: Safety Overview

Metric UBIDECARENONE UPADACITINIB
Total FAERS Reports 361 65,656
Deaths Reported 5 2,406
Death Rate 1.4% 3.7%
Hospitalizations 194 15,931
Average Patient Age 60.7 yrs 57.4 yrs
% Female Patients 82.6% 71.2%
FDA Approval Date N/A Apr 26, 2024
Manufacturer Energique, Inc. AbbVie Inc.
Route ORAL ORAL
Marketing Status N/A Prescription